Intern, Corporate Communications: June-August 2027 (Hybrid)
- Acton, Massachusetts
- Internship
- $25.00 - $34.00
- Posted
Skills
Job description
Job Summary
Intern, Corporate Communications: June-August 2027 (Hybrid) Position Dates: June 7, 2027 – August 13, 2027
We are seeking a dynamic and detail-oriented Corporate Communications Intern to support the execution of our internal and external communications strategy. This student-level role will focus on supporting the development and distribution of content across digital platforms, including internal emails, newsletters, social media, and web content, as well as assisting with asset management (photos, videos, documents, etc.). The ideal candidate is a strong writer and content creator with an interest in gaining experience in a fast-paced corporate environment.
Key Responsibilities:
Internal Communications:
Qualifications:
Preferred Skills and Competencies:
This position is not eligible for employer-based visa sponsorship. Candidates must have authorization to work in the U.S. without current or future sponsorship needs.
Additional Information:
Compensation & Benefits: For U.S.-based positions only, the annual base salary range for this role is $25.00 - $34.00 This position may also be eligible for incentive compensation. We offer a comprehensive benefits package, including: • Medical insurance • Holiday pay • Sick time off • And additional employee wellness programs Application Details: This job posting will remain open until the position is filled. To apply, please visit the Insulet Careers site and submit your application online. Actual pay depends on skills, experience, and education.
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible personal smartphone in the U.S. or by the Omnipod 5 Controller. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit insulet.com and omnipod.com.
We are looking for highly motivated, performance-driven individuals to be a part of our expanding team. We do this by hiring amazing people guided by shared values who exceed customer expectations. Our continued success depends on it!
At Insulet Corporation all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran.
( Know Your Rights )